A5092856204- Cardiomyopathy and Myosin Studies
- Cardiovascular Function and Risk Factors
- Cardiovascular Issues in Pregnancy
Federal Almazov North-West Medical Research Centre
2023-2024
North-Western State Medical University named after I.I. Mechnikov
2021
Despite the fact that principles of diagnosing hypertrophic cardiomyopathy (HCM) are clearly defined in current guidelines, real clinical practice one has to deal with a large number comorbid patients where diagnosis HCM is not so obvious. Objective . To analyze and demographic characteristics referred Almazov National Medical Research Center HCM. Design methods The registry included 1168 who were provisionally or definitively diagnosed period from 2010–2021. Out them, 280 excluded study....
Aim . To develop predictive models for differential diagnostics of hypertrophic phenotype in patients with concomitant diseases, as well to validate through independent assessment. Material and methods The study included an analysis 1169 medical records from the information system severe myocardial hypertrophy a preliminary diagnosis cardiomyopathy (HCM) (I42.1, I42.2). were divided into 3 following groups: probable HCM, moderate (>15 mm) due known disease, that cannot be explained by...
Abstract Introduction The number of cases hypertrophic cardiomyopathy (HCM) in pregnancy increases every year. In most the course is favorable, however certain high–risk scenarios there an increased risk complications (e.g., ventricular ectopic activity, heart failure exacerbation). Management heavily relies on severity outflow tract obstruction, extent left hypertrophy and sudden cardiac death (SCD) stratification. Purpose main objective this study to assess factors during pregnancy,...